HPV Vaccines

Human Papillomavirus (HPV) vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.

These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.

  • Advances in HPV Vaccine
  • HPV Vaccines for Men
  • HPV Vaccine risks and controversies
  • HPV Vaccine for Women

Related Conference of HPV Vaccines

July 27-28, 2018

31st Annual Congress on Vaccines & Clinical Trials

Vancouver, Canada
Aug 27-29, 2018

Annual Congress and Expo on Vaccines & Immunology

Amsterdam, Netherlands
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan

HPV Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in